After man says dog dewormer cured his cancer, researchers look into treatment

    Tocotrienol and Tocopherol forms (all 8)  of Vitamin E (400-800mg per day, 7 days a week).  
        A product called Gamma E by Life Extension or Perfect E are both great.

    Bio-Available Curcumin (600mg per day, 2 pills per day 7 days a week).  
        A product called Theracurmin HP by Integrative Therapeutics is bioavailable., and

    CBD oil (1-2 droppers-ful [equal to 25mg per day] under the tongue, 7 days a week) oil

    Panacur C (fenbendazole) (1 GRAM PER DAY FOR 3 CONSECUTIVE DAYS) per week.  
        Take 4 days off and repeat each week.  
        Each gram of Panacur C has approximately 222 mg of fenbendazole,

It wasn’t as awkward as that opening photo.

https://www.livescience.com/61057-liver-flukes-vietnam-veter...

To avoid them, make sure freshwater fish in SE Asia is fully cooked.

The strange thing is that the affinity of benzimidazole anthelmintics to mammalian tubulin is much lower than to roundworm tubulins, but as we say, more research is needed.

I have a family member who cannot take various common medicines, not because of the active ingredient (which they need) but because of the inactive ones which are generally considered safe.

Conversely, it is possible for a substance which is not shown to have a general effect in a study to have an effect specifically for a person or small group of people. Discounting this and hiding behind "evidence based medicine" is not helpful.

The problem is they're too damn expensive. There is a huge number of people willing to put almost anything in their body in the hope it might help (animal remedies, herbs, homeopathic remedies, etc).

If we could harness these people into cheap double-blind trials, we could advance science much quicker and cheaper. I'm thinking something along the lines of "you tell us what pseudoscience remedy you want, and we'll return either it or a placebo with 50/50 chance, and then you self-report the results to us".

Joe Tippens was only given three months to live. But doctors later enrolled him in a clinical trial they hoped could give him more time.

Tippens said he received a tip from a veterinarian who suggested he try a dog dewormer drug called fenbendazole, which was believed to display cancer-fighting properties, according to cell studies.

In his blog, Tippens wrote that after receiving his fourth cancer-free diagnosis at the University of Texas MD Anderson Cancer Center in Houston last April, the results indicated that his cancer was gone after two years of treatment.

Dr. Stephen Prescott, Oklahoma Medical Research Foundation president, said Tippens’ story interested him after speaking to a scientist at Johns Hopkins University who conducted a case study where scientists implanted immune-deficient mice with human tumors.

While the experiment was still in progress, a veterinarian at Johns Hopkins University put the mice on the same deworming medications that Tippens used.

After examining the results, scientists found that the implanted tumors would not grow, he said.

“They were trying to make cancer in mice and unbeknownst to them, something that the veterinarian in the facility had done prevented that,” Prescott said.

Shortly after, Prescott said he met Tippens through mutual friends.

While director of the Huntsman Cancer Institute in Salt Lake City, Prescott said he “would hear stories all the time about new approaches to cancer medical treatments,” but remained skeptical.

However, Prescott said he and a team Tippens is putting together will collaborate to explore alternative care methods.

“It would be a wonderful thing if we discovered that there is this compound that has broad activity with dramatic responses like with Mr. Tippens, what a great thing that would be,” he said.

Prescott said they plan to spend six to 12 months researching the medical records of cancer patients.

In their study, they will consider specifics such as the treatment they received, how they reacted and how long they were given to live.

By studying Tippens’ case further, Prescott said they could provide more truth to the dog dewormer medicinal impact.

One problem made evident by some anticancer medications is that over time they become ineffective, he said.

It is the reason why patients today are seeking other treatments.

Most anticancer drugs attack a specific target on or in the cancer cell, he explained.

“What often happens is that it works initially and then quits working,” Prescott said.

“And the reason is the cancer has continued to change and have additional mutations, so what was the initial targets no longer respond to the drug.”

Part of Tippens’ treatment regimen was CBD.

Chip Paul, the founder of Owasso-based GnuPharma, a company that specializes in developing natural products, said he is unsure how influential CBD alone was on Tippens’ cancer cells.

“If he was just taking cannabidiol, it is doubtful that it affected his cancer because it does not have the right actives in it to be able to signal that,” Paul said.

Prescott said as the clinical trial develops, he hopes that it will eventually lead to answers regarding Tippens’ shocking recovery.

“I do really applaud Mr. Tippens for his forthrightness and aggressive stance for something he believes has helped him and can help us as a people,” Prescott said.

“He has done more than any patient has done in that regard.”

Tippens said he received a tip from a veterinarian who suggested he try a dog dewormer drug called fenbendazole, which was believed to display cancer-fighting properties, according to cell studies.

In his blog, Tippens wrote that after receiving his fourth cancer-free diagnosis at the University of Texas MD Anderson Cancer Center in Houston last April, the results indicated that his cancer was gone after two years of treatment.

Dr. Stephen Prescott, Oklahoma Medical Research Foundation president, said Tippens’ story interested him after speaking to a scientist at Johns Hopkins University who conducted a case study where scientists implanted immune-deficient mice with human tumors.

While the experiment was still in progress, a veterinarian at Johns Hopkins University put the mice on the same deworming medications that Tippens used.

After examining the results, scientists found that the implanted tumors would not grow, he said.

“They were trying to make cancer in mice and unbeknownst to them, something that the veterinarian in the facility had done prevented that,” Prescott said.

Shortly after, Prescott said he met Tippens through mutual friends.

While director of the Huntsman Cancer Institute in Salt Lake City, Prescott said he “would hear stories all the time about new approaches to cancer medical treatments,” but remained skeptical.

However, Prescott said he and a team Tippens is putting together will collaborate to explore alternative care methods.

“It would be a wonderful thing if we discovered that there is this compound that has broad activity with dramatic responses like with Mr. Tippens, what a great thing that would be,” he said.

Prescott said they plan to spend six to 12 months researching the medical records of cancer patients.

In their study, they will consider specifics such as the treatment they received, how they reacted and how long they were given to live.

By studying Tippens’ case further, Prescott said they could provide more truth to the dog dewormer medicinal impact.

One problem made evident by some anticancer medications is that over time they become ineffective, he said.

It is the reason why patients today are seeking other treatments.

Most anticancer drugs attack a specific target on or in the cancer cell, he explained.

“What often happens is that it works initially and then quits working,” Prescott said.

“And the reason is the cancer has continued to change and have additional mutations, so what was the initial targets no longer respond to the drug.”

Part of Tippens’ treatment regimen was CBD.

Chip Paul, the founder of Owasso-based GnuPharma, a company that specializes in developing natural products, said he is unsure how influential CBD alone was on Tippens’ cancer cells.

“If he was just taking cannabidiol, it is doubtful that it affected his cancer because it does not have the right actives in it to be able to signal that,” Paul said.

Prescott said as the clinical trial develops, he hopes that it will eventually lead to answers regarding Tippens’ shocking recovery.

“I do really applaud Mr. Tippens for his forthrightness and aggressive stance for something he believes has helped him and can help us as a people,” Prescott said.

“He has done more than any patient has done in that regard.”

GDPR compliance can be extremely expensive to implement, especially for complex software comprised of thousands of microservices that handle customer data. And imagine working in an industry where data retention is legally mandated by other jurisdictions...

I'm not saying GDPR is bad (I'm all in favor!), but the costs can be quite large to implement to the letter of the law (GDPR export requirements, etc)

"COKE ROT Cocaine can ROT your skin and genitals – as drug is cut with dangerous cattle de-wormer, experts warn"

the interesting thing is in the article it says cocaine can be cut with Levamisole, which:

was used to treat arthritis and bowel cancer in the past, but it was banned for use by humans in 2000....Now, it's only supposed to be used in veterinary medicine to kill parasitic worms.

If an EU citizen/resident/etc accessed the site from a country that’s not blocked, or via VPN, are they unable to ask for their information or have it scrubbed?

What if a person later becomes an EU citizen?

What if they are a dual citizen?

I don’t understand how these geo blockers are able to make anyone compliant.